URBN
42
4
XRX
41
6
EXC
56
2
BXP
52
2
NTRS
57
2
JPM
67
4
MAR
65
2
MTCH
42
5
PAYX
51
4
STX
56
4
ROST
52
5
CNP
63
3
DD
60
4
MU
36
5
DVN
18
2
KEY
43
3
FLR
55
6
HST
58
18
M
25
5
MMC
60
6
URBN
42
4
XRX
41
6
EXC
56
2
BXP
52
2
NTRS
57
2
JPM
67
4
MAR
65
2
MTCH
42
5
PAYX
51
4
STX
56
4
ROST
52
5
CNP
63
3
DD
60
4
MU
36
5
DVN
18
2
KEY
43
3
FLR
55
6
HST
58
18
M
25
5
MMC
60
6
Financhill
Back

Akero Therapeutics Vs. Target Industry Stock Comparison

Buy
65

AKRO
Akero Therapeutics

Last Price:
31.18
Seasonality Move:
5.92%
Sell
20

TGT
Target

Last Price:
124.92
Seasonality Move:
4.08%
Buy
65
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $31.20. The Score for AKRO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Target (TGT) is a Sell

Is Target a Buy, Sell or Hold?

  • The current Target [TGT] share price is $121.59. The Score for TGT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • TGT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $31.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

TGT Stock Price Chart

What is Target's stock price today?

  • The Target share price today is $121.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGT is experiencing slight selling pressure.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.2 Buy
Relative Strength Index (14 RSI): 51.61 Buy
Chaikin Money Flow: 477302 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.34 - 33.04) Buy
Bollinger Bands (100): (24.94 - 30.5) Buy

TGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.85 Sell
Relative Strength Index (14 RSI): 23.91 Sell
Chaikin Money Flow: -8404826 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (140.56 - 157.62) Sell
Bollinger Bands (100): (142.35 - 156.95) Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.45 Buy
20-day SMA: 31.54 Sell
50-day SMA: 29.74 Buy
200-day SMA: 25.28 Buy
8-day EMA: 30.86 Buy
20-day EMA: 30.99 Buy
50-day EMA: 29.83 Buy
200-day EMA: 27.24 Buy

TGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 146.51 Sell
20-day SMA: 148.61 Sell
50-day SMA: 151.64 Sell
200-day SMA: 153.85 Sell
8-day EMA: 141.24 Sell
20-day EMA: 147.16 Sell
50-day EMA: 149.8 Sell
200-day EMA: 149.63 Sell

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.

Target Earnings Growth & TGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.33 per share, an increase this year of $2.81 per share, and an increase next year of $0.38 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Target Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):